(精编)【医学英文课件】 DAN-NOAC教学课件.pptVIP

The Danish Non-vitamin K-antagonist Oral Anticoagulation Study – A Cluster Randomized Study DAN-NOAC www.dannoac.dk Af L?ge Casper N. Bang, PhD Baggrund AF samt VTE (dyb venetrombose og lungeemboli) → invaliderende sygdom og d?dsfald. Fire non-vitamin K antagonist Orale anticoagulantia (NOACs) 3 direkte faktor Xa-h?mmer?: Apixaban (Eliquis, Bristol-Myers Squibb): ARISTOTLE, AMPLIFY Rivaroxaban (Xarelto, Bayer): ROCKET, EINSTEIN DVT/PE Edoxaban (Lixiana, Daiichi-Sankyo): ENGAGE AF-TIMI 48, Hokusai-VTE 1 trombinh?mmer: - Dabigatran (Pradaxa, Boehringer Ingelheim): RE-LY, RE-COVER/ RE-C